In vitro remodelling of plasma lipoproteins in whole plasma by lipoprotein lipase in primary and secondary hypertriglyceridaemia

European Journal of Clinical Investigation
E LevyC C Roy

Abstract

In patients with familial lipoprotein lipase deficiency (FLPL-d) and glycogen storage disease type I (GSD-I), hypertriglyceridaemia (1445 +/- 247 and 1082 +/- 312 mg dl-1, n = 5 per group) was associated primarily with reduced extrahepatic lipoprotein lipase (LPL) activity (0.33 +/- 0.33 and 1.69 +/- 0.38 mumol FFA ml-1 h-1) when compared with controls (4.83 +/- 0.90). Hypercholesterolaemia was characterized by elevated LDL cholesterol (191 +/- 30 and 344 +/- 34 vs. 115 +/- 5 mg dl-1 in controls P less than 0.01) and low HDL cholesterol (12 +/- 2 and 22 +/- 2 vs. 56 +/- 3 in controls, P less than 0.001). In order to ascertain the role of LPL in the interconversion and remodelling of lipoproteins in these disorders, we analysed lipid and lipoprotein profiles before and following in vitro incubation of patient plasma with purified milk LPL (EC 3.1.1.34) for 6 h at 37 degrees C. The efficiency of exogenous LPL in vitro was demonstrated by the extent of hydrolysis of chylomicrons and of VLDL-TG in both groups. Concomitant with the disappearance of TG-rich lipoprotein particles, a consistent per cent increment of IDL (99.2 +/- 30.8 and 43.9 +/- 70.5), LDL (152.8 +/- 36.2 and 137.0 +/- 36.1) and of HDL2 (144.8 +/- 29.4 and 99.8 +/- 1...Continue Reading

References

Sep 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J R PatschS Eisenberg
Nov 30, 1978·The New England Journal of Medicine·A R Tall, D M Small
Jan 1, 1986·Methods in Enzymology·S Eisenberg
Feb 1, 1987·American Heart Journal·W C Breckenridge
Dec 20, 1973·Biochimica Et Biophysica Acta·S EisenbergF T Lindgren
Nov 1, 1969·The Journal of Clinical Investigation·D S FredricksonF T Lindgren
Mar 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·J R PatschA M Gotto
May 1, 1982·Metabolism: Clinical and Experimental·F C BallantyneD Ballantyne
Jan 1, 1980·Annual Review of Biochemistry·P Nilsson-EhleM C Schotz
Mar 12, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·G SchmitzB Melnik
Oct 14, 1982·Biochimica Et Biophysica Acta·P GambertP Padieu

❮ Previous
Next ❯

Citations

Feb 10, 1999·The American Journal of Physiology·M ZoltowskaE Levy
Apr 15, 1996·Thrombosis Research·K KeddadA Legrand
Feb 1, 1996·Clinical Biochemistry·K KeddadA Legrand
Jun 6, 1994·The American Journal of Medicine·D J Betteridge
Jun 1, 1997·Metabolism: Clinical and Experimental·R M FisherS W Coppack

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.